FDA NDC Directory · JSON-LD · Markdown

BUPRENORPHINE AND NALOXONE

NDC 67877-607 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214930
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE HYDROCHLORIDE (2 mg/1)
NALOXONE HYDROCHLORIDE (.5 mg/1)
Marketing started20260703
Package count3

External sources

Source: openFDA. Public-domain (CC0).